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Human mesangial cells secrete a GBM-degrading neutral
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Human mesangial cells secrete a GBM-degrading neutral proteinase
and a specific inhibitor. The factors operative during normal and disease
states which govern the degradation of the glomerular extracellular
matrix (ECM, glomerular basement membrane and mesangial matrix)
remain poorly understood. These structures consist primarily of types
IV and V collagen, which are highly resistant to the action of classical
interstitial collagenases. Here we report that an intrinsic glomerular cell
type, the human mesangial cell, secretes: 1) a neutral proteinase with
specific activity against type IV basement membrane collagen and, 2) an
inhibitory protein with the characteristics of the tissue inhibitor of
metalloproteinases (TIMP). The purified enzyme has a neutral pH
optimum, consists of a basic (p1 8.4) protein doublet with molecular
weight of 66 and 68 kilodaltons, and is inhibited by calcium and zinc
chelators. The enzyme degrades both soluble and basement membrane
type IV collagen, but does not specifically degrade types I or V collagen
or casein. Immunohistochemistry of cultured cells demonstrated homo-
geneous staining for the neutral proteinase antigen, while the TIMP
antigen was detected in fewer than one-third of cultured cells. These
findings suggest that the synthesis of these proteins may be indepen-
dently regulated. The secretion of these factors may play an important
role in the turnover of the glomerular ECM under basal or pathologic
conditions.
The glomerular basement membrane (GBM) and the mesan-
gial matrix represent the key structural elements of the renal
glomerulus. This highly specialized extracellular matrix is com-
posed primarily of type IV collagen, along with lesser propor-
tions of type V collagen, fibronectin, laminin and other matrix
constituents [11. The GBM and mesangial matrix are frequently
affected by the numerous pathologic processes which can
involve the glomerulus. On the one hand, proteolytic destruc-
tion of the basement membrane may lead to proteinuria and loss
of glomerular filtration function. Alternatively, many glomeru-
lar diseases are characterized by a progressive accumulation of
extracellular matrix in the mesangium, a process resulting in
glomerulosclerosis. As in other tissues, the quantity of the
glomerular extracellular matrix is the result of a balance be-
tween synthetic and degradative processes. To date, the mech-
anisms governing the catabolism of these critical elements
remain poorly understood.
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The degradation of the ECM in connective tissues composed
primarily of types I or III collagens is presently viewed as a
multi-step process. This process includes the interaction of a
series of extracellularly active neutral proteinases with matrix
substrates and with specific inhibitors, such as the tissue
inhibitor of metalloproteinases (TIMP) [2—6]. Matrix degrada-
tion begins with the action of extracellular collagenases which
specifically cleave interstitial collagens [7—11]. Following spe-
cific collagen cleavage, less specific enzymes, such as gelati-
nase and stromelysin, further degrade the collagen fragments to
smaller peptides [12—16]. These peptides are subsequently
endocytosed and degraded by the action of intracellular lyso-
somal enzymes [17]. The collagen types IV and V present
within normal glomeruli are highly resistant to the classical
interstitial collagenases, suggesting that other extracellularly
active enzymes are involved in the normal catabolism of the
glomerular extracellular matrix. There is evidence that neutral
proteinases with primarily gelatinolytic activity can degrade
these substrates [18, 19]. In addition, collagen type IV and V
specific collagenases have been isolated from the culture super-
nates of macrophages and certain tumor cell lines [20—26].
Previous studies from our laboratories have partially charac-
terized a rat mesangial cell neutral metalloendopeptidase with
degradative activity against the type IV collagen of isolated
GBM [27, 28]. Based on these observations, it was elected to
purify, more extensively characterize, and develop specific
antibodies to a similar activity present in the culture supernates
of human glomerular mesangial cells. This reports details the
purification and characterization of this enzyme as a gelatinase
with type IV collagen degrading activity and provides new
evidence that human mesangial cells also secrete the proteinase
inhibitory protein, TIMP.
Methods
Materials
(3H)-acetic anhydride (19.7 mCi/mmol) and En3Hance were
obtained from New England Nuclear (Boston, Massachusetts,
USA). Chromatographic media, electrophoresis supplies and
calibration kits were from Pharmacia (Piscataway, New Jer-
sey). RPMI 1640, heat-inactivated fetal calf serum and antibi-
otics were from Gibco (Grand Island, New York, USA).
Bacterial collagenase (type IV) was from Sigma (St. Louis,
Missouri, USA). Native, soluble type IV collagen and ITS (5
p.g/ml transferrin, 5 jig/ml insulin and 5 ng/ml selenous acid,
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final concentrations) were from Collaborative Research (Bos-
ton, Massachusetts, USA). The type IV collagen was extracted
from the EHS tumor and consisted primarily of pro-al and
pro-a2 (IV) chains, along with lesser amounts of mature al and
a2 (IV) chains. YM-10 ultrafiltration membranes were from
Amicon Corp. (Danvers, Massachusetts, USA). Horseradish
peroxidase-conjugated goat anti-rabbit IgG was obtained from
Cappel (Cochranville, Pennsylvania, USA). Purified human
recombinant TIMP (clone BPA) and specific rabbit anti-TIMP
IgG were from D. Cosman, The Immunex Corp. (Seattle,
Washington, USA).
Establishment of human mesangial cell cultures
Human kidney was obtained at the time of elective nephrec-
tomy from patients with various forms of well-circumscribed
renal neoplasia. Primary cultures of human mesangial cells
were established from collagenase-treated glomeruli as recently
reported in detail [29, 30]. The growth medium consisted of
RPM! 1640 supplemented with 20% heat-inactivated fetal calf
serum, 50 U/mI penicillin, 50 gIml streptomycin, and 300
,.tg/ml glutamine. ITS was routinely added to all culture media.
Cellular outgrowths appeared within five days and consisted of
interwoven, strap-like cells. Small clusters of these cells were
picked out, replated and grown to confluency. The cultures
were subsequently rapidly expanded and uniform populations
were frozen in liquid nitrogen at the fourth to sixth passage. For
experiments, the cells were thawed, plated in growth medium,
grown to subconfluency and used as detailed below.
The cells were characterized as intrinsic mesangial using
previously reported criteria [27, 29, 30]. Immunofluorescence
(IF) staining revealed prominent intracellular myosin fibrils
arranged along the long axis of the cells. IF was negative for
Factor VIII, common leukocyte antigen, and Ia antigen. Con-
fluent cultures were multilayered, and there was no morpho-
logic evidence for the presence of either glomerular endothelial
or epithelial cells, which grow in monolayers of polygonal cells
[31]. For preparation of conditioned media, subconfluent cul-
tures were washed extensively with phosphate-buffered saline
(PBS) and further cultured for up to five days in serum-free
RPMI 1640 containing 0.2% lactalbumin hydrolysate. The con-
ditioned media were collected, centrifuged at 1000 g for 10
minutes and stored at —20°C prior to enzyme assay or purifi-
cation procedures.
Preparation of enzyme substrates
Type I collagen was extracted from rat tail tendon and
radiolabelled with (3H)-acetic anhydride as described by Caw-
ston and Barrett [32]. The labelled collagen was diluted with
cold collagen to give a final solution containing I mg/mI (specific
activity 1 x l0 dpm/mg) and stored at —80°C until use. Gelatin
substrate was prepared by incubating the radiolabelled type I
collagen preparation at 60°C for one hour. Casein and native
soluble type IV collagen were labelled in the same manner to
specific activities of I x iø dpm/mg and 2 x l0 dpmls sg,
respectively. Pepsin-solubilized type V collagen was prepared
from human placenta according to Madri [33]. Insoluble canine
glomerular basement membrane (GBM) was prepared accord-
ing to Meezan et al [34].
Enzyme assays
The culture media and purified preparations were assayed for
interstitial collagenase activity using the diffuse fibril method of
Cawston and Barrett [32]. 3H-collagen (100 g) was incubated
at 35°C with 100 pJ assay buffer (100 mii Tris/HC1, pH 7.6, 15
mM CaCl, 0.025% Brij) and 100 pi sample for up to 18 hours.
Non-digested collagen was pelleted by centrifugation and the
radioactivity in the supernate quantitated by liquid scintillation
counting. Gelatinase activity was assayed according to Murphy
et al [35]. 3H-gelatin (100 jsg) was incubated at 37°C with 50 d
assay buffer (400 ms'i Tris/HC1, pH 8.0, 10 m CaC12, 0.025%
Brij) and 100 sl sample for up to 18 hours. Following trichloro-
acetic acid (TCA) precipitation, supernate radioactivity was
quantitated as above. The degradation of casein was assayed as
described by Adams [36]. As a positive control for caseinase
activity, extracts of human polymorphonuclear leukocyte gran-
ules were prepared according to Baugh and Travis [37]. In each
case the presence of latent enzyme was determined by the
addition of p-aminomerduric acetate (PAMA) to the incubation
buffers at a final concentration of 1 mri [32]. One unit of
enzymatic activity was defined as that amount of enzyme which
degraded 1 pg substrate/hr under the individual assay condi-
tions.
The activity of the purified neutral proteinase against radio-
labelled native soluble type IV collagen was determined by
incubating 5 g labelled substrate with 0.34 U of the purified
enzyme at 31°C in 100 mri Tris/HC1, pH 7.6, 15 mri CaCl2,
0.025% Brij. Following incubation, the samples were solubi-
lized in reducing sample buffer and analyzed by SDS-PAGE and
autoradiography. The activity of the neutral proteinase against
type V collagen was determined by incubating 15 tg substrate
with 1 U purified enzyme at 31° and 37°C, followed by SDS-
PAGE.
The degradation of insoluble GBM by the purified neutral
proteinase was assessed by incubating 1 mg of a lyophilized
GBM preparation with 4 U enzyme at 31°C for 24 to 72 hours.
Following incubation, the non-digested GBM was pelleted by
centrifugation and the supernate assayed for hydroxyproline as
described by Bergman and Loxley [38].
TIMP assay
TIMP activity was measured by the inhibitory action of serial
dilutions of test materials against a known quantity of the
purified mesangial neutral proteinase using the gelatinase assay
detailed above. The activity is expressed as the per cent
inhibition as compared to controls containing purified enzyme
alone [391.
Electrophoretic procedures
Analytic SDS-PAGE was performed on vertical slab gels
according to Laemmli [40]. For the separation of collagens, 2 M
urea was included in the gel buffer. For the visualization of
non-radioactive materials, fixed gels were stained with either
Coomassie blue R-250 or silver nitrate. For radiolabeled sub-
strates, the gels were fixed, stained and soaked in En3Hance.
Following drying under heat and vacuum, radiolabelled bands
were localized by autoradiography using Kodak X-O-Mat film
and enhancing screens.
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Table 1. Purification of mesangial neutral proteinase
Step
Total protein
mg
Total activity
U
Specific activity
U/mg P factor
Cond. Med 163.00 132.3 0.8 1
YM-lO membrane 15.40 512.7 33.1 40.9
SepharoseS200 5.67 1189.0 201.7 249.1
Sepharose 4B 2.87 1439.0 508.4 627.7
Heparin Sepharose 1.56 1200.0 759.6 937.7
Purification table of mesangial neutral proteinase activity. Results are expressed in terms of gelatinase activity and are representative of five
individual purification runs. All data are expressed as the means of triplicate determinations of enzymatic activity or protein content.
SDS-substrate gels were prepared by including gelatin in the
standard Laemmli acrylamide polymerization mixture at a final
concentration of 1 mg/mI. The samples were solubilized in
nonreducing sample buffer and electrophoresed at 7°C, using 25
mA/gel. Following electrophoresis, the gels were washed in
cold 50 mss Tris/HCI, pH 8, containing 50 mrs NaC1, 10 mM
CaC12 and 0.05% Brij 35. The gels were then incubated over-
night in fresh Tris buffer at 37°C. Thereafter the gels were
stained with Coomassie Blue and zones of lysis visualized.
Standard proteins were utilized for assignation of molecular
weight. Analytical isoelectric focusing (IEF) was performed on
0.4 mm polyacrylamide slabs [41]. Concentrated, purified neu-
tral proteinase was dialyzed against 1% glycine and focused at
continuous power (8 watt/gel) for 60 minutes following 30
minutes of prefocusing. Focused gels were fixed in 10% tn-
chloroacetic acid/30% ethanol, post-fixed in 5% trichloroacetic/
30% ethanol, washed twice in deionized water and stained with
silver. The p1 of the purified enzyme was determined by
comparison with stained standard proteins (Pharmacia IEF
Standard Kit).
Immunologic methods
Highly purified neutral proteinase was electrophoresed in
10% gels and stained with silver nitrate. The protein band at 66
kd was identified, cut out, homogenized into Freund's adjuvant
and used to prepare rabbit hyper-immune serum by standard
methods. Anti-neutral proteinase IgG was prepared by ammo-
nium sulfate precipitation and anion exchange chromatography.
For Western blot analysis, electrophoresed proteins were trans-
ferred to nitrocellulose membranes. The membranes were
blocked, probed with 1 xg/ml anti-neutral proteinase IgG and
developed with biotinylated goat anti-rabbit IgG and alkaline
phosphatase-coupled biotin-avidin complexes. For dot-blot
analysis of TIMP antigens, serial dilutions of recombinant
TIMP standard (clone BPA) and partially purified mesangial cell
TIMP were applied to nitrocellulose membranes, probed with 1
xg/ml rabbit anti-recombinant TIMP IgG and developed as
above.
For immunohistochemistry, human mesangial cells were cul-
tivated on etched glass cover slips. The cells were fixed with
3.7% paraformaldehyde, 1 ifiM MgCI2, 0.1 mri CaCl2, for 20
minutes at 25°C. The fixed cells were washed three times in
PBS, 0.1% BSA (PBS-BSA) and permeabilized by incubation in
0.01% Triton X-100 for 90 seconds. The cells were washed and
incubated for two to four hours with 1 pgIml rabbit anti-neutral
proteinase IgG or rabbit anti-TIMP IgG in PBS-BSA. The slides
were washed, incubated for two hours with a 1: 100 dilution of
peroxidase-conjugated goat anti-rabbit IgG, washed again and
incubated with 1.5% glutaraldehyde in 0.1 M sodium cacody-
late, pH 7.6, containing 5% sucrose for 15 minutes. Thereafter,
the slides were washed and incubated with 3, 3' diaminobenzi-
dine, H202 and NiCI2 according to Hsu and Soban [42]. The
slides were washed, counterstained with Mayer's hematoxylin
and mounted. Controls included studies with pre-immune rabbit
IgG as the primary antibody and peroxidase-conjugated goat
anti-rabbit IgG used in the absence of a primary antibody.
For immuno-electron microscopy the cultured cell layers
were fixed in 0.1% glutaraldehyde, 3.7% paraformaldehyde in
sodium cacodylate buffer containing 300 m sucrose. The fixed
cells were washed and infiltrated with half-strength LR White
resin (Ted Pella, Redding, California, USA). These were then
removed by gentle scraping, pelleted and embedded in full-
strength resin. Ultrathin sections were cut, mounted on acid-
cleaned nickel grids and blocked with 1% BSA in PBS. The
grids were incubated overnight at 4°C with 1 g/ml rabbit
anti-NP or anti-TIMP IgG in PBS-BSA. Washed grids were
subsequently incubated for one hour with protein A-gold com-
plexes at a 1: 10 dilution (15 nm particles, E-Y Labs, San
Mateo, California, USA). Washed grids were stained with lead
citrate and uranyl acetate, air-dried and examined with a
Phillips 201 electron microscope. Controls included grids incu-
bated with pre-immune IgG or with protein A-gold complexes
alone.
Results
Purification of mesangial neutral proteinase activity
Conditioned medium from cultured human MC was initially
screened for neutral proteinase activity against several relevant
substrates, including type I collagen, gelatin, casein, fibronectin
and laminin. In most culture preparations gelatinolytic activity
was readily detected, while little or no activity against the other
substrates was observed. Gelatinolytic neutral proteinase was
present in the conditioned medium primarily in the latent form
and could be activated by incubation with the organic mercu-
rial, p-aminomercuric acetate (PAMA). This gelatinolytic activ-
ity was subsequently purified using an approach summarized in
the accompaning purification table (Table 1).
Crude conditioned medium was concentrated by ultraldiafil-
tration against a YM-lO membrane (10 kd cutoff) and applied to
a calibrated column of Sephacryl S200 SF (Fig. lA). Gelati-
nolytic activity was regularly eluted at an apparent molecular
wt of approximately 60 to 70 kd. The late eluting peak of
activity shown in Figure 1A was not regularly obtained and
represents a partial degradation product of the intact enzyme
(data not shown). The initial peak of gelatinolytic activity was
0
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pooled, concentrated and applied to a column of Sepharose CL
4B (Fig. 1B). Neutral proteinase activity was again eluted as a
broad peak with apparent molecular wt of 60 to 68 kd. These
initial steps removed the bulk of the protein contaminants
present in the starting material. As shown in Table 1, a large
increment in the apparent total enzyme activity developed
during the process of purification. Such an event is indicative of
a protease inhibitor in the starting material, which is subse-
quently separated out during purification. The characterization
of this inhibitory activity (which represents TIMP) is detailed
below. In view of this, and the reported affinity of TIMP for
heparin-Sepharose [39], the neutral proteinase activity was
further purified by passage through a column of this matrix
equilibrated with 20 mrt Tris/HC1, pH 7.6, 10 mrvi CaCl2, 0.05%
Brij 35. The bulk of the neutral proteinase activity was not
bound under these conditions, which yielded an enzyme prep-
aration with a final specific activity of approximately 759 U/mg
and a purification factor of 930-fold.
SDS-PAGE and silver protein staining following heparin-
Sepharose chromatography indicated that the highly purified
enzyme consisted of a protein doublet with molecular wt of 68
and 66 kd (Fig. 2, lane b). While a doublet was always obtained,
the relative amounts of the 66 and 68 kd components varied
among several preparations of mesangial conditioned medium.
10 20 30 40 .50
Fraction number
0.20
0.16
0.12
0.08
0.04
0 10 Fig. 1. Purification of mesangial neutralproteinase activity-gel chromatographic
separation. A. Crude conditioned medium was
0.08 concentrated by ultra/diafiltration against a
YM-lO membrane and applied to a calibrated
0.06 B 2.5 X 70 cm column ofSephacryl S200 SF
equilibrated with 150 mi NaCI, 10 msi Tris/
0 04 HC1, pH 7.6, 0.025% Brij 35 and eluted withthe same buffer. Fractions of 3 ml were
assayed for total NP (gelatinase) activity (S)0.02 3 as detailed in Methods. B. The peak of NP
activity eluting at approximately 60 to 70 kd
from the Sephacryl S200 column was
concentrated and applied to a calibrated 2.5 x
70 cm column of Sepharose CL-4B using the
buffer system detailed in A.
The enzymatic activity of these purified proteins in gelatin
substrate gels is shown in Figure 2, lane c. Alter removal of
SDS, the gels were incubated overnight at 37°C and stained with
Coomassie blue. The pale areas represent zones of gelatinase
activity and match up precisely with the silver stained proteins
in lane b. It should be noted that a reliable estimate of the
relative specific activity of each component of the protein
doublet could not be made using this technique, primarily due
to the variable enzyme diffusion which occurs during the
overnight incubation. Further biochemical characterization of
the purified neutral proteinase was provided by analytic isoelec-
tric focusing (IEF, Fig. 3). IEF of the enzyme on ultra-thin layer
acrylamide slabs demonstrated a very closely migrating protein
doublet with a basic p1 of approximately 8.4.
The highly purified neutral proteinase was most active in a
limited temperature range between 35° and 42°C (Fig. 4A). A
relatively broad pH optimum for enzymatic activity was ob-
served, primarily in the neutral range between pH 6 and 8 (Fig.
4B). The inhibitory profile of the neutral proteinase is provided
in Table 2. Enzymatic activity was readily inhibited by the
chelators, EDTA and EGTA. The zinc chelator, 1, lO-phenan-
throline, was also an effective inhibitor. The enzyme was
inhibited by the reducing agents DTT and cysteine, but was not
significantly affected by serine or carboxyl proteinase inhibitors
794 Martin et a!: Glomerular matrix metabolism
Fig. 2. Biochemical characterization of mesangial neutral proteinase
(gelatinase) activity. SDS-PAGE analysis: Samples containing crude
conditioned medium, (lane a), and highly-purified neutral proteinase
following heparin-Sepharose chromatography, (lane b), were electro-
phoresed on 7.5% reducing gels and stained for protein using silver
nitrate. An additional sample, (lane c), of purified NP was electro-
phoresed under non-reducing conditions in a 7.5% gel containing 1
mg/ml gelatin. Enzymatic activity is demonstrated by zones of substrate
lysis in stained gels (arrows). The faint band at 90 kd represents
aggregate formation which frequently occurs in the non-reduced gelatin
gels.
or by phosphoramidon. Coupled with the pH optima, this
profile is quite characteristic of a calcium, zinc-dependent,
neutral metalloproteinase.
The highly purified neutral proteinase was tested against a
number of different substrates in order to define its specificity.
Insignificant activity was detected against 3H-casein (Fig. 5).
The incubation of labelled type I collagen with 1.6 (gelatinase)
U of purified neutral proteinase consistently yielded less than
3% of the radioactivity released from labelled gelatin (3.3 x iø
dpm) of the same specific activity incubated under indentical
conditions (triplicate measurements). In addition, no activity
was detected against purified laminin or fibronectin substrates
(data not shown). The enzyme did degrade native soluble type
IV collagen (Fig. 6). These incubations were performed at 31°C
in order to prevent thermal degradation (gelatinization) of the
type IV collagen substrate. The results indicated that both the
pro-al and pro-a2 IV chains, as well as the processed al and a2
IV chains, are extensively degraded by the purified mesangial
neutral proteinase. Furthermore, this enzyme was active at
incubation temperatures of 31°C against the insoluble form of
native type IV collagen present in glomerular basement mem-
brane, resulting in a time-dependent release of hydroxyproline
from the GBM substrate (Fig. 7). Significant degradation of type
A B
Fig. 3. Analytic isoelectrofocusing of pur(fled mesangial neutral pro-
teinase. Purified enzyme was concentrated, dialyzed against 1% glycine
and focused on 0.4 mm acrylamide slabs as detailed in Methods.
Focused slabs were fixed and stained with silver nitrate. Lane a, stained
standards: i-p1 9.3; 2-pI 8.65; 3-p1 8.45; 4-pI 8.15; 5-pI 7.35; 6-pI 6.55;
7-pI 5.85; 8-pI 5.20; 9-pI 4.55. Lane b, purified neutral proteinase; the
arrow denotes the major bands at p1 8.3 to 8.4.
V collagen substrate by the neutral proteinase was not observed
at 31°C (Fig. 8). Incubation at 37°C resulted in extensive
degradation of this substrate, presumably the result of the
thermal denaturation (gelatinization) of the type V collagen.
Characterization of mesangial TIMP activity
The large increment in total apparent neutral proteinase
activity detected during purification suggested the presence of
an inhibitor in the initial material. In order to characterize this
activity more completely, a quantitative assay was established.
This assay determined the degree of inhibition of a known
quantity of purified neutral proteinase by serial dilutions of test
materials [391. Crude mesangial conditioned medium was con-
centrated 50-fold by ultraldiafiltration into 150 m'vi NaC12, 10
mM Tris/HCI, pH 7.6, 0.025% Brij 35 and assayed for NP
inhibitory activity. Typical results are shown in Figure 9A, and
demonstrate the presence of large amounts of inhibitory activ-
ity. Gel chromatography of this material (Fig. 9B) yielded a
major peak of inhibitory activity eluting with an apparent
molecular weight of 28 to 30 kd, which is the size of the TIMP
protein purified from other cellular sources [6, 43, 441. This
partially purified material was further evaluated by semi-quan-
titative immunoblot analysis using a rabbit polyclonal IgG
prepared against the human recombinant TIMP protein (Fig.
10). These studies demonstrate the immunologic similarity of
a116 — S— 8
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Fig. 4. Temperature and pH optima of the
purified mesangial neutral proteinase. Known/ quantities of purified enzyme activity (as definedin the standard assay run at pH 8.0, 37°C) were
incubated at the designated temperatures (A) or
buffer pH (B) and the amount of activity
determined. Data are given as means of triplicate
4 5 6 7 8 9 10 determination. Symbols are (0) 0.1 M sodium
acetate; (•) 0.1 M sodium cacodylate; (0) 0.1 M
pH Tris/HC1; (U) 0.1 M giycine/NaOH).
Table 2. Inhibitor profile of mesangial neutral proteinase
%
Inhibitor Concentration Inhibition
EDTA 10mM
1mM
99
54
EGTA 10mM 95
1,10 Phenanthroline 10 mM
1mM
100
38
Dithiothreitol 10 mM
2mM
1mM
82
24
9
Cysteine 10 mi 60
Pepstatin 5 g/m1 11
SBTI I mg/mi 15
PMS-F 10mM 11
NEM 10mM
1mM
9
10
Phosphoramidon 100 pg/mi
10 ig/ml
3
4
Inhibitor profile of the purified mesangial neutral proteinase. For
these studies 2 U enzyme (100% active) were preincubated for 60
minutes at 25°C with the various inhibitors, followed by the standard
assay for gelatinase activity. Results are expressed as the % inhibition
as compared to controls maintained in buffer alone. Data represent the
means of triplicate to quadruplicate determinations, where the average
SD was approximately 15%.
the recombinant TIMP protein with the mesangial cell inhibitor.
Additional quantitation using this technique indicated that
crude mesangial conditioned medium contains approximately 4
to 6 ng/ml of TIMP antigen.
Fig. 5. Absence of sign jficant caseinase activity by the purified neutral
proteinase. 3H-casein substrate was incubated in buffer alone (lane A),
with a polymorphonuclear leukocyte granule extract (lane B) or with 1.6
U purified neutral proteinase (lane C), followed by SDS-PAGE and
autoradiography.
Immunohistochemical analysis
A rabbit polyclonal antineutral proteinase IgG was prepared
by immunization with the purified neutral proteinase. For these
studies, the neutral proteinase was electrophoresed and the
band of enzymatic activity at 66 kd was used for immunization.
This antibody was characterized as shown in Figure 11. The
Western blot (lane B) shows two protein bands at 66 and 68 kd,
which precisely match the bands of enzymatic activity seen in
the accompanying gelatin substrate gel (lane A). These findings
indicate that the two neutral proteinase bands are immunolog.
ically related and presumably represent post-translational var-
iants of the same core protein, as has been reported for
interstitial collagenase [10, 111.
Using this anti-neutral proteinase antibody, cultured human
mesangial cells were examined by the immunoperoxidase tech-
nique (Fig. 12). Neutral proteinase antigen was detected in
nearly 100% of the cells, with prominent perinuclear staining
(Fig. 12B). Parallel studies, employing a rabbit anti-recombi-
nant TIMP IgG preparation, also demonstrated cellular staining
for the TIMP antigen (Fig. 12C). In contrast to the distribution
of neutral proteinase antigen, the TIMP antigen was expressed
by fewer than one-third of the mesangial cells evaluated.
Immuno-gold electron microscopy was performed to localize
the intracellular distribution of the NP and TIMP antigens (Fig.
13). The TIMP antigen was detected within the prominent rough
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Fig. 6. Degradation of native, soluble type IV collagen by purified
mesangial neutral proteinase. 3H-type IV collagen (2 x iO dpm/5
tg/probe) was incubated with buffer alone (c) or with purified enzyme
(np) at 31°C for the times indicated. The digestion products were
separated by SDS-PAGE and visualized by autoradiography. (185 and
175 refer to the migratory positions of the pro-al and pro-a2 type IV
collagen chains).
These studies indicate that cultured human mesangial cells
release at least two proteins which may directly regulate
glomerular matrix catabolic processes. A gelatinolytic neutral
proteinase activity was readily detected in culture supernatants
and was present in substantial quantity. Extensive biochemical
and immunologic efforts to detect, or uncover, other specific
neutral proteinase activities against interstitial collagens, fi-
bronectin or laminin were unsuccessful. The gelatinolytic ac-
tivity was purified to a high degree of purity in relatively few
steps, primarily because of its abundance and the use of a
serum-free starting material. The enzyme was secreted in a
latent form, and could be readily activated by incubation with
organomercurials. The activation of metalloproteinases by or-
ganomercurials is related to the induction of protein conforma-
tional changes and has been recently discussed in detail for
interstitial collagenase [45]. The purified enzyme is a typical
calcium, zinc-dependent metalloproteinase with a neutral pH
optimum. Biochemical characterization indicated that the en-
zyme is a basic protein and exists as a doublet of 68 and 66 kd.
Both components of this doublet are enzymatically active and
are immunologically identical. Interstitial collagenase demon-
strates a very similar doublet pattern, which is the result of
F I
0 24 48 96
Time, hours
Fig. 7. Degradation of insoluble type IV collagen from glomerular
basement membrane (GBM) by purified mesangial neutral proteinase.
GBM (1 mg) was incubated with 4 U purified enzyme at 31°C for the
times indicated, Supernatant hydroxyproline was determined as de-
tailed in Methods. The data are the means I SD of triplicate
incubations. Symbols are: (0) controls; (A) NP.
NP4h NP24h C NP4h NP24h C
31 C 37C
Fig. 8. Degradation of type V collagen by purified mesangial neutral
proteinase. Type V collagen (15 sg/probe) was incubated with I U
purified enzyme at 31° and 37°C for the times indicated, followed by
SDS-PAGE and protein staining. The arrows denote the purified neutral
proteinase doublet.
variable post-translational glycosylation of a common core
protein [11]. The substrate studies indicate that the specific
activity of the enzyme is restricted to gelatin and the soluble
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endoplasmic reticulum of the cultured cells (Fig. l3B). An
identical pattern was obtained for the NP antigen (not shown).
Clusters of NP antigen, in sizes compatible with typical secre-
tory vesicles, were noted immediately beneath the plasma
membrane in many cells (Fig. l3C). These findings suggest that
the NP and TIMP proteins are processed through conventional
cellular synthetic and secretory pathways and provide unequiv-
ocal evidence for the mesangial cellular origin of these mole-
cules.
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B
Fig. 9. A. Titration curve of neutral
proteinase inhibitory activity (TIMP) present
in 50-fold concentrated mesangial conditioned
medium. Serial dilutions of conditioned
medium were incubated with a known
quantity of purified neutral proteinase and the
degree of inhibition determined. Data are
means of triplicate determinations. B.
Sephacryl S200 SF gel chromatography of
TIMP activity. Crude conditioned medium
was concentrated and applied to a calibrated
column using the buffer conditions detailed in
Figure 1. Fractions (3 ml) were assessed for
inhibitory activity in the TIMP assay. The
0 10 20 30 40 50 largest peak of activity eluted with an
apparent molecular weight of approximately
Fraction no. 28 to 30 kd.
Fig. 11. Characterization of the rabbit anti-human mesangial neutral
proteinase antibody preparation. Rabbit hyper-immune anti-neutral
proteinase IgG was prepared as detailed in Methods and used as a probe
for Western blots of electrophoresed, purified neutral proteinase (lang
B). The antigens at 66 and 68 kd line up precisely with the bands of
gelatinolytic activity demonstrated by the purified enzyme preparation
(lane A). The faint upper band in lane B is a transfer artifact present in
non-loaded lanes.
specific metalloproteinase has been purified from the culture
supernatants of the murine PMT sarcoma and human mononu-
clear phagocytes [20—22]. The murine enzyme exists as a
doublet of 68 and 62 kd and cleaves type IV collagen pro-al and
pro-a2 chains in a specific and limited manner. The mononu-
clear cell neutral proteinase exists as a single component of 68
kd, is significantly glycosylated, and has an acidic p1 of 5.2.
This enzyme also cleaves type IV collagen in a specific and
limited manner. The activities of these enzymes against gelatin
Fig. 10. Immunologic characterization of the mesangial proteinase
inhibitor as TIMP. Serial dilutions of a human recombinant TIMP
standard (B PA) and the 28 to 30 kd peak of mesangial inhibitor obtained
by gel chromatography were probed with rabbit anti-recombinant TIMP
IgG and developed as detailed in Methods. A 1: 128 dilution of the TIMP
standard corresponds to approximately 16 ng antigen.
and insoluble forms of type IV collagen. In particular, no
activity of the purified enzyme was detected against interstitial
collagen or casein. The biochemical properties of the enzyme,
combined with the substrate specificities, clearly distinguish the
mesangial cell neutral proteinase from classical interstitial col-
lagenase or stromelysin [15, 16].
In addition to the interstitial collagenases which are active
against types I and III collagen, a number of type-specific
enzymes have been variably characterized. A type IV collagen
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Fig. 12. Immunohistochemical staining of cultured
human mesangial cells for neutral proteinase and TIM?
antigens. Cells were fixed and stained as detailed in
Methods. A. Controls incubated with pre-immune rabbit
IgG and second antibody, DAB/H202 (x 960). B.
Neutral proteinase staining (x 1200). Permeabilized
cells uniformly demonstrated prominent granular
perinuclear localization of the NP antigen. C. TIMP
staining (x 1200). The center cell exhibits very
prominent perinuclear localization of antigen. Note the
adjacent cell which lacks demonstrable intracellular
TIMP antigen.
or other relevant substrates have not been reported. A type V
collagen specific enzyme, which also cleaves gelatin, has been
purified from rabbit and human alveolar macrophages [24—261.
This enzyme has a molecular weight of 90 kd and immunolog-
ically cross-reacts with human neutrophil granule gelatinase
[46].
Several primarily gelatinolytic enzymes have also been de-
scribed. Fibroblasts from human gingiva secrete a gelatinase
with molecular wt of 72 kd, which has little activity against
casein or interstitial collagen [47]. Gelatin-degrading activities
have also been characterized in supernatants of cultured human
skin fibroblasts and peripheral mononuclear cells [13, 48]. In
none of these cases was activity against types IV or V collagen
assessed. A gelatinase from rabbit bone cultures has been more
extensively characterized by Murphy and colleages [19]. This
enzyme has a molecular wt of 65 kd and is capable of degrading
both types IV and V collagen, although degradation of the later
substrate was highly temperature dependent. The susceptibility
of type IV collagen to degradation by such a variety of discrete
enzymatic activities may be related to the existence of non-
collagenous sequences within the triple helix of the molecule
[49]. The actual relationship of the mesangial enzyme to these
varied activities is presently unclear, but should be clarified in
the near future through the use of appropriate cDNA or protein
sequence analyses such as those used for interstitial collagenase
and stromelysin [10, 16, 50]. The biochemical and inhibition
profiles of the mesangial NP clearly distinguish it from the
kidney brush border metallo-endopeptidases meprin and en-
dopeptidase 24.11 [51].
The classification of the mesangial inhibitory activity is less
difficult. Conditioned media contained appreciable quantities of
a functional metalloproteinase inhibitor. Partial purification of
this inhibitory factor yielded a protein with a molecular wt of 28
to 30 kd, which is the size of the TIMP protein isolated from a
number of tissues [4—6, 39]. This functional and structural
similarity was extended by the observation that the MC inhib-
itor is antigenically related to the recombinant TIMP protein.
The extensive comparative studies of Welgus and Stricklin [52]
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Fig. 13. Immuno-gold electron microscopic localization of NP and
TIMP antigens. Cells were prepared as detailed in Methods. A.
Controls incubated with pre-immune rabbit IgG and protein A-gold
complexes. No specific antigen localization is revealed (x 42,000). B.
Localization of TIMP antigen. The association of gold particles in
linear arrays (arrows) with the abundant RER is notable (x 50,000).
C. NP localization. Two prominent clusters of gold particles (arrows)
are noted over sub-plasmalemma structures the size of typical
secretory vesicles (x 75,000).
have demonstrated the virtual identity of all TIMP-like mole-
cules isolated from multiple cell types, and it would appear that
the mesangial-derived TIMP is no exception to this rule.
The preparation of specific antibodies to the neutral protein-
ase and TIMP proteins permitted further insights into the
cellular distribution of these substances. Neutral proteinase
antigen was present in nearly 100% of the mesangial cells and
was also noted in macroscopic accumulations of extracellular
matrix present in long-term cultures (unpublished observa-
tions). A similar extracellular matrix localization has been
previously described for interstitial collagenase, an event which
involves only the active form of the enzyme [53, 54]. The
prominent perinuclear staining for neutral proteinase resembles
that observed for interstial collagenase, and represents local-
ization of the antigen in the abundant rough endoplasmic
reticulum of these cells. Neutral proteinase activity could also
be demonstrated on the mesangial cell surface using gelati-
nolytic assays of isolated plasma membrane preparations (un-
published observations). The cell surface localization of colla-
gen and gelatin-degrading metalloproteinases on certain tumor
cells has been previously reported and may impart these cells
with the ability to destroy surrounding connective tissue matrix
[55, 561. Others have noted that the collagenase associated with
the surface of gingival fibroblasts is active when the plasma
membrane contacts collagen fibrils [57]. In contrast to the
neutral proteinase antigen, TIMP was detected in a minority
(approximately 30%) of mesangial cells cultured under identical
conditions. TIMP antigen was noted in the perinuclear cyto-
plasm of permeabilized cells, a pattern consistent with studies
of cultured chondrocytes and fibroblasts [58]. Little or no cell
surface staining was detected.
Our results considerably extend previous studies concerning
the neutral proteinase activity released by cultured rat mesan-
gial cells [27, 28]. The human neutral proteinase shares with the
rat enzyme similar molecular characteristics and substrate
specificities for gelatin and type IV collagen. In contrast to the
findings reported here, the rat enzyme can also degrade to some
extent type V collagen. Significantly, we have not been able to
detect TIMP activity in the culture supernates of rat mesangial
cells. The finding that human mesangial cells secrete both TIMP
and the neutral proteinase in culture will permit more compre-
hensive studies of the cellular regulation of these factors.
At the present time we can only speculate about the potential
roles of the mesangial cell neutral proteinase and TIMP proteins
in the regulation of glomerular matrix catabolism. There is a
normal basal turnover of glomerular basement membrane and
mesangial matrix, and it may be that the neutral proteinase is
involved in these normal regulative events [59—61]. Equally
significant may be the augmented release of the neutral protein-
ase during glomerular inflammation. Previous studies have
demonstrated that interleukin 1 induces both mesangial cell
proliferation and enhanced synthesis of the neutral proteinase
[62—64]. Mesangial hypercellularity and cytoplasmic interpos-
tion between the endothelium and the basement membrane are
frequent occurrences in glomerular disease, conditions under
which peptide mitogen-induced synthesis of proteolytic en-
zymes could result in severe structural damage. Alternatively,
diseases characterized by accumulation of glomerular extracel-
lular matrix, such as diabetic glomerulosclerosis, may be due to
decreased activity of the neutral proteinase or excess secretion
of the inhibitory TIMP protein. Ongoing immunohistochemical
studies of human biopsy tissue, which have demonstrated the
presence of the neutral proteinase and TIMP antigens, may be
expected to help clarify these important issues and to provide
further insights into the regulation of the glomerular extracel-
lular matrix.
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Appendix. Abbreviations
Abbreviations used are: GBM, glomerular basement membrane;
ECM, extracellular matrix; TIMP, tissue inhibitor of metalloprotein-
ases; ITS, insulin, transferrin, selenium; PBS, phosphate-buffered
saline; TCA, trichloroacetic acid; PAMA, p-aminomercuric acetate;
IEF, isoelectric focusing; BSA, bovine serum albumin; PMS-F, phe-
nylmethylsulfonyl-fluoride; SBTI, soya bean trypsin inhibitor; NEM,
N-ethylmaleimide.
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